Calamos Advisors’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Calamos Advisors’s Portfolio TDACW Stock Details TDACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$265K	Hold	185,766	–	–	﹤0.01%	904
2026 Q2	$245K	Buy	+185,766	New	+$186K	﹤0.01%	896

Other funds holding TDACW

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $447M AUM 5.09% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return

Gritstone Asset Management Bethesda, Maryland $103M AUM 5.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Calamos Advisors's TDACW Position: Q3 2026 in Review

Calamos Advisors held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q3 2026 at 185,766 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #904.

Calamos Advisors first reported a position in TDACW in Q2 2026 and has held it in 2 quarters since. 7 funds tracked by Wall St. Rank hold TDACW as of Q3 2026.

Calamos Advisors held 185,766 shares of Translational Development Acquisition Corp Warrants worth $265K as of Q3 2026.
Calamos Advisors left its Translational Development Acquisition Corp Warrants share count unchanged in Q3 2026.
Translational Development Acquisition Corp Warrants made up ﹤0.01% of Calamos Advisors's portfolio in Q3 2026, its #904 holding.
Calamos Advisors first reported a position in Translational Development Acquisition Corp Warrants in Q2 2026 and has held it in 2 quarters since.
7 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q3 2026.

Based on Calamos Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.